Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2)
(VERDICT-2 Trial)
Trial Summary
What is the purpose of this trial?
The VERDICT-2 verification study will examine the accuracy of the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model: CVSM-1A) in an ambulatory context with healthy participants. The objective is to determine the accuracy of continuous non-invasive vital signs metrics including respiration, pulse rate, oxyhemoglobin saturation (SpO2), core temperature, heart rate, and cNIBP against standard comparator devices guided by consensus standards.
Research Team
Maura Marcucci, M.D., MSc
Principal Investigator
McMaster University, Population Health Research Institute
Michael McGillion, PhD
Principal Investigator
McMaster University, Population Health Research Institute
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Vitaliti Continuous Vital Sign Monitor Model CVSM-1A (Continuous Vital Signs Monitor)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hamilton Health Sciences Corporation
Lead Sponsor
McMaster University
Collaborator
Population Health Research Institute
Collaborator
Cloud DX Inc.
Industry Sponsor